Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ pcDNA™6.2/V5-PL-DEST Mammalian Expression Vector
Designed for high-level, constitutive expression in variety of mammalian cell lines
Supplier: Invitrogen™ 12537162
Includes: All destination vectors are provided lyophilized and supercoiled.
Requires : Gateway™ entry clone, appropriate Gateway™ LR Clonase enzyme mix, and reaction buffer.
Description
- Promoterless version of pcDNA™6.2/V5-DEST vector
- attR sites for Gateway cloning
- Compatible with MultiSite Gateway Pro kits
- C-terminal V5 tag for easy detection
- Blasticidin resistance gene for efficient stable selection
- Ampicillin resistance gene and pUC origin for selection and maintenance in E. coli
- Gateway Cloning Destination vectors have attR sites for recombination with any attL-flanked fragment, regardless of whether it is an entry clone or an UltimateORF Clone
Cloning,Constitutive Expression,Gateway Cloning,Mammalian Expression,Multi-Gene Expression,Multisite Gateway,Protein Expression,Proteins, Expression, Isolation and Analysis
Specifications
Transfection | |
None (Promoterless) | |
All destination vectors are provided lyophilized and supercoiled. | |
C-terminal | |
Gateway | |
pcDNA, pDEST, MultiSite Gateway Vectors | |
Clone your own Promoter, Multi-Gene Expression |
MultiSite Gateway™ Pro kits (e.g. cat. no. 12537-100) | |
Mammalian Expression Vector | |
Mammalian | |
V5 Epitope Tag | |
6 μg | |
Gateway™, pcDNA™ |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Provide Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
For Research Use Only. Not for use in diagnostic procedures.
Spot an opportunity for improvement?
Provide Content Correction